Haloperidol Decanoate 200mg Monthly Conversion to Oral Daily Dose
Haloperidol decanoate 200 mg given monthly as a long-acting injection is approximately equivalent to 10 mg of oral haloperidol daily.
Conversion Calculation
The conversion from haloperidol decanoate LAI to oral haloperidol follows a well-established multiplication factor:
- Standard conversion factor: 10-20 times the daily oral dose = monthly decanoate dose 1, 2, 3
- Working backwards: 200 mg decanoate ÷ 20 = 10 mg oral daily
- Alternative calculation: 200 mg decanoate ÷ 10 = 20 mg oral daily (upper range)
The most commonly used and evidence-supported conversion is the 20-fold factor, meaning 200 mg monthly decanoate corresponds to approximately 10 mg oral haloperidol daily 1.
Evidence Supporting This Conversion
Research demonstrates that:
- The 20-fold schedule (daily oral dose × 20 = monthly decanoate dose) proved adequate in most patients and became the standard conversion 1
- A study directly comparing oral to decanoate formulations used 9.4 to 15 times the daily oral dose for monthly injections, with patients remaining clinically stable 3
- Pharmacokinetic studies confirm that 15-20 times the oral daily dose produces therapeutic plasma levels equivalent to oral administration 2, 4
Pharmacokinetic Considerations
Key pharmacokinetic differences between formulations:
- Haloperidol decanoate reaches peak plasma levels within 3-7 days after injection 4
- Steady-state is achieved after 2-3 monthly injections (approximately 3 months) 1, 4
- The half-life is approximately 3 weeks (21 days), justifying monthly administration 2, 4
- Plasma levels during decanoate treatment are often lower than during oral treatment, yet patients remain clinically stable, suggesting sustained therapeutic effect 3
Clinical Application
When converting between formulations:
- From oral to decanoate: Multiply daily oral dose by 20 (e.g., 10 mg oral daily → 200 mg decanoate monthly)
- From decanoate to oral: Divide monthly decanoate dose by 20 (e.g., 200 mg decanoate monthly → 10 mg oral daily)
- The conversion factor range of 10-20 is acceptable, with 20 being most commonly used and evidence-supported 1, 2
Important Caveats
- Oral supplementation may be needed during the first 1-2 months when initiating decanoate, as steady-state takes 2-3 injection cycles to achieve 4
- Individual patient factors (metabolism, drug interactions, clinical response) may require dose adjustments from these general conversion guidelines 5, 6
- The dose range for haloperidol decanoate in clinical trials was 50-300 mg monthly, with 200 mg showing a 15% symptomatic exacerbation rate versus 60% with 25 mg 7